ITMCTR2100004336招募中4 期
A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Wen Capsule/Granule in the treatment of asymptomatic patients with novel coronavirus pneumonia
Hebei Province Chest Hospital0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 —（—）
- 性别
- All
入选标准
- •1. Asymptomatically infected with novel coronavirus pneumonia discovered through pathogenic testing;
- •2. Over 18 years old (including 18 years old);
- •3. Voluntarily sign a written informed consent before the study begins.
排除标准
- •1. Patients with new coronavirus pneumonia confirmed by pathogenic testing and clinical manifestations or signs;
- •2. In the opinion of the investigatorpatients with serious diseases such as malignant disease, autoimmune disease, liver and kidney disease, blood disease, neurological disease, and endocrine disease may affect patients' participation in the trial or influence the outcome of the study;
- •3. Pregnant or lactating women;
- •4. Patients who participated in other clinical trials within the last 3 months;
- •5. An allergic condition, such as a history of allergies to two or more drugs or foods, or a known allergy to the ingredients of the drug;
- •6. The investigator believes that there are any factors that are not suitable for enrollment or affect the evaluation of the efficacy.
研究者
相似试验
已完成
不适用
A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)ITMCTR2000003320The First Affiliated Hospital of Wenzhou Medical University
招募中
4 期
A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000002975Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
招募中
4 期
A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of severe novel coronavirus pneumoniaovel Coronavirus Pneumonia (COVID-19)ITMCTR2100004363Hebei Province Chest Hospital
进行中（未招募）
1 期
A Study of the Safety of Intravenous Brincidofovir for Adenovirus InfectioTreatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipientsMedDRA version: 20.1 Level: PT Classification code 10060931 Term: Adenovirus infection System Organ Class: 10021881 - Infections and infestationsEUCTR2017-003984-37-ESChimerix, Inc30
进行中（未招募）
1 期
A Study of the Safety of Intravenous Brincidofovir for Adenovirus InfectioTreatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipientsMedDRA version: 21.1Level: PTClassification code 10060931Term: Adenovirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-003984-37-ITCHIMERIX, INC.30